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Objectives. This study evaluated the effect of high intensity
drive train (S1) stimulation on the atrial effective refractory
period (ERP) and its relation to the autonomic nervous system.
Background. High intensity S1 stimulation was demonstrated
to shorten the ventricular ERP and to increase dispersion of
refractoriness. These effects may be due to local release of
neurotransmitters. The response of the atrium and ventricle to
neurotransmitters was different. The effects of high intensity S1
stimulation at the atrial tissue were evaluated.
Methods. Forty patients without structural heart disease were
studied. In group 1, 20 patients, the atrial ERP was measured at
0, 7, 14, 21 and 28 mm away from the S1 site under both twice
diastolic threshold and high intensity (10 mA) S1 stimulation. The
same protocol was repeated after sequential administration of
propranolol (0.2 mg/kg body weight) and atropine (0.04 mg/kg). In
group 2, the other 20 patients, the atrial ERP was studied at three
atrial sites (high lateral right atrium [HLRA], right posterior
interatrial septum [RPS] and distal coronary sinus [DCS] with
twice diastolic threshold and high intensity S1 stimulation at
baseline and after sequential autonomic blockade. The three
atrial sites were randomly assigned as the S1 location.
Results. In group 1, high intensity S1 stimulation shortened the
atrial effective refractory period most prominently at the site of S1:
(mean 6 SD) 13.3 6 6.4% (p < 0.001), 8.1 6 3.8% (p < 0.001),
4.8 6 4.3% (p < 0.001), 3.7 6 4.7% (p < 0.001) and 0.5 6 2.6% at
0, 7, 14, 21 and 28 mm from the S1 site, respectively. The effect of
high intensity S1 stimulation was blunted with propranolol and
autonomic blockade but persisted after atropine alone. High
intensity S1 stimulation also increased dispersion of refractori-
ness (from 23 6 11 ms to 31 6 12 ms, p 5 0.01), which was
eliminated with autonomic blockade. In group 2, high intensity S1
stimulation had similar effects at different locations (ERP short-
ening of 10.8 6 2.7%, 10.8 6 2.2% and 12.2 6 4.6% at the HLRA,
RPS and DCS, respectively). The responses to sequential auto-
nomic blockade were similar to those in group 1. However, high
intensity S1 stimulation at HLRA increased dispersion of refrac-
toriness, but at DCS it reduced dispersion of refractoriness.
Conclusions. High intensity S1 stimulation led to local short-
ening of the atrial ERP and increased dispersion of refractoriness.
These effects were blunted with propranolol and autonomic block-
ade. High intensity S1 stimulation at the HLRA increased disper-
sion of atrial refractoriness, whereas the same stimulation at the
DCS decreased dispersion of atrial refractoriness.
(J Am Coll Cardiol 1997;29:1000–6)
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An increase in drive train (S1) pacing stimulus intensity has
been reported (1,2) to significantly shorten the effective refrac-
tory period (ERP) in both atrial and ventricular tissue. Lang-
berg et al. (2) demonstrated that autonomic blockade blunted
the effect of increased S1 stimulus intensity on the ventricular
effective refractory period (VERP) (3). In addition, high
intensity S1 stimulation was reported to increase the dispersion
of refractoriness. Local release of catecholamines was impli-
cated as the mechanism of these effects. The response to high
intensity S1 stimulation of the atrium may differ from that of
the ventricle because the anatomic structure and autonomic
innervation of the atrium and ventricle differ (4–6). We
conducted this prospective study to evaluate the effect of high
intensity S1 stimulation on spatial distribution of refractoriness
in the atrium and to investigate the role of autonomic neuro-
transmitters in this effect.
Methods
Study patients. This study included 40 patients with su-
praventricular tachycardia (19 with atrioventricular (AV) node
reentrant tachycardia, 10 with Wolff-Parkinson-White syn-
drome with orthodromic AV reciprocating tachycardia, 11 with
AV reciprocating tachycardia incorporating a concealed acces-
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sory pathway). They were referred for electrophysiologic study
and radiofrequency catheter ablation because of refractoriness
to or intolerance of a mean 6 SD of 2 6 1 antiarrhythmic
drugs. None had structural heart disease or spontaneous atrial
flutter or fibrillation. Group 1 consisted of 20 patients, 10 men
and 10 women with a mean age of 42 6 18 years (range 14 to
73). Group 2 consisted of another 20 patients, 12 men and 8
women with a mean age of 50 6 21 years (range 17 to 81).
Different stimulation protocols were performed in the two
groups.
Refractory period determinations. The study protocol was
approved by the Committee of Human Subject Research at
this institute. All patients were studied in the postabsorptive,
nonsedated state after they had provided written informed
consent, and the antiarrhythmic drugs had been discontinued
for .5 half-lives. Electrode catheters were positioned in the
high lateral right atrium (HLRA), right posterior interatrial
septum (RPS), His bundle area, coronary sinus and right
ventricle. Surface electrocardiographic leads I, II and V1 and
intracardiac electrograms were displayed on an oscilloscope
and recorded at a paper speed of 100 to 200 mm/s, as needed.
Intracardiac electrograms were filtered from 50 to 500 Hz.
Pacing was performed with a programmable stimulator
(Bloom Associates) with one or two stimulus isolation units as
needed, using 2-ms rectangular pulses.
To assure the stability, all refractory period determinations
were performed after continuous atrial pacing at a 400-ms
cycle length for 2 min. An extrastimulus (S2) was initially
coupled at an interval less than that of the atrial refractory
period with increases of 2-ms every fourth beat until capture
(7). The S2 stimulus strength was set at two times the late
diastolic threshold for all determinations. When the S1 and S2
stimulation sites were the same, the atrial ERP was defined as
the longest S1–S2 interval that consistently failed to evoke an
atrial depolarization. If the S1 and S2 stimulation sites differed,
the conduction time from the S1 to the S2 site during contin-
uous pacing was measured. The atrial ERP at the test site was
defined as the longest S1–S2 interval that failed to evoke an
atrial depolarization minus the conduction time from the S1
site to the S2 site (3).
Spatial effect of high intensity S1 stimulation on atrial refrac-
toriness. In group 1, the effect of distance from the stimulation
site on the shortening of atrial refractoriness resulting from
high intensity (10 mA) S1 stimulation was evaluated. A custom-
designed decapolar 7F catheter (Daig) was positioned at the
HLRA; each bipolar pacing had the capture threshold
,1.0 mA. The five pairs of electrodes had 2-mm interelectrode
spacing within each pair and 5-mm spacing between each pair
(2-5-2-5-2-5-2-5-2 configuration), and each pair was used for
stimulation and recording. Thus, the spacing between each pair
was 7 mm. The position of the catheter was periodically
checked by fluoroscopy to ascertain the stability of the catheter
during the whole study procedure.
The S1 stimulation site was the distal set of electrodes for all
refractory period determinations. Atrial ERP determinations
were made at each of the five sets of electrodes along the
catheter in random order. At each site, the atrial ERP was
determined by use of an S1 stimulus intensity of two times the
diastolic threshold (of the distal set of electrodes) and 10 mA.
At least 120 s was required to elapse between atrial ERP
determinations at different S1 stimulus intensities. The S2
strength was set at two times the late diastolic threshold of
each site for determinations at both S1 stimulus intensities.
Propranolol (loading dose 0.2 mg/kg body weight, followed by
1 mg/min) and atropine (0.04 mg/kg) were infused in random
sequence after baseline ERP determination (8). ERP determi-
nations were repeated 5 min after loading of each drug. Thus,
10 patients (group 1A) received propranolol infusion followed
by atropine infusion; another 10 patients (group 1B) received
atropine infusion followed by propranolol infusion. During
each drug infusion, the sinus cycle length was maintained at
,20 ms variation.
Effect of high intensity S1 stimulation at different locations. In
group 2, to evaluate the effects of high intensity S1 stimulation
at different atrial locations, three atrial sites (HLRA, RPS and
distal coronary sinus [DCS]) were selected for S1 stimulation in
random sequence. Thus, two quadripolar catheters with 2-mm
interelectrode spacing within each pair of electrodes and 5-mm
spacing between each pair (2-5-2 configuration, Mansfield)
were positioned at the HLRA and the lower RPS, and one
steerable decapolar catheter (2-5-2-5-2-5-2-5-2 configuration,
Daig) was used to cannulate the coronary sinus with the distal
pair of electrodes for pacing or recording. At each site, two
times diastolic threshold and 10 mA were used as S1 stimulus
intensity, and the S2 strength was set at two times the late
diastolic threshold for all determinations. A capture threshold
,1.0 mA was required at all three sites. The refractory period
was measured at the HLRA by use of S1 stimulation from the
HLRA, RPS and DCS. The refractory periods were also
measured at the RPS and DCS by use of S1 stimulation from
all three sites. Thus, 18 refractory period determinations were
made in random sequence. Propranolol (loading dose
0.2 mg/kg, followed by 1 mg/min) and atropine (0.04 mg/kg)
were infused in random sequence after the baseline study.
Atrial refractory period determinations were repeated after
each infusion. Thus, 10 patients (group 2A) received an
infusion of propranolol followed by atropine; another 10
patients (group 2B) received an infusion of atropine followed
by propranolol.
Abbreviations and Acronyms
ANOVA 5 analysis of variance
AV 5 atrioventricular
DCS 5 distal coronary sinus
ERP 5 effective refractory period
HLRA 5 high lateral right atrium
RPS 5 right posterior interatrial septum
S1 5 drive train
S2 5 extrastimulation, extrastimulus
VERP 5 ventricular effective refractory period
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Definition. Dispersion of refractoriness was defined as the
longest atrial ERP minus the shortest atrial ERP. In group 1,
the dispersion of refractoriness was obtained from five atrial
sites; in group 2, the dispersion of refractoriness was obtained
from the three atrial sites (HLRA, RPS and DCS).
Statistical analysis. All data are presented as mean
value 6 SD. A Student t test was used to compare paired data.
A two-way repeated measures analysis of variance (ANOVA)
combined with the Duncan multiple range test was used to
evaluate the effects of sequential autonomic blockade on high
intensity S1 stimulation at different locations. A p value , 0.05
was considered statistically significant.
Results
Spatial effect of high intensity S1 stimulation on atrial
refractoriness. Baseline variables. For group 1 patients, the
late diastolic capture thresholds at each of the five test sites
(from distal to proximal) were 0.56 6 0.22, 0.52 6 0.20, 0.55 6
0.18, 0.52 6 0.14 and 0.52 6 0.14 mA, respectively (p . 0.05,
by ANOVA). The capture thresholds at each site remained
similar after sequential autonomic blockade. At an S1 stimulus
intensity of two times the diastolic threshold, there was no
significant difference between atrial ERPs measured at each
site (Fig. 1A). When both S1 and S2 stimuli were delivered at
the distal electrode, the mean atrial ERP decreased from
188 6 23 ms at an S1 stimulus intensity of two times the
diastolic threshold to 164 6 21 ms at an S1 stimulus intensity of
10 mA (p , 0.0001). When S2 was delivered 7, 14 and 21 mm
away from the S1 stimulation site, the high intensity S1
stimulation significantly decreased the mean atrial ERP from
186 6 21 to 171 6 19 ms, 187 6 18 to 178 6 22 ms, 190 6 15
to 183 6 15 ms at each site, respectively (p , 0.001). However,
when S2 was delivered 28 mm away from the S1 site, the ERP
was not decreased significantly by the high intensity (10 mA) S1
stimulation (189 6 15 vs. 188 6 17 ms, p . 0.05) (Fig. 1A).
When the S1 stimulus intensity was increased from twice
diastolic threshold to 10 mA, the ERP shortened significantly
(p , 0.001). The degree of shortening of the ERP decreased
gradually as the S2 sites moved away from the S1 stimulation
site: 225 6 11 ms (213.3 6 4.5%) at 0 mm, 215 6 7 ms
(28.2 6 3.4%) at 7 mm, 29 6 8 ms (24.8 6 4.9%) at 14 mm
and 27 6 7 ms (23.6 6 3.5%) at 21 mm away from the S1
stimulation site. At 28 mm away from the site of S1 stimulation,
there was no significant shortening of the ERP with an increase
in the S1 stimulus intensity (21 6 3 ms [20.7 6 1.7%]) (Fig.
1B).
Effect of autonomic blockade. After propranolol infusion,
the ERP at five test sites significantly increased (Fig. 2A). In
contrast to the effect of propranolol, the ERP after atropine
shortened significantly at five test sites (Fig. 3A). The degree of
Figure 1. A, Atrial effective refractory period (ERP) obtained at atrial
stimulation at two times diastolic capture threshold (open bars) and 10
mA (hatched bars). Location 5 distance from the driving site. *p ,
0.01. B, Percent shortening of the atrial ERP by high intensity drive
train stimulation (high current S1) stimulation. The data in A and B are
presented as mean value 6 SD.
Figure 2. A, Effect of propranolol and total autonomic blockade on
ERP at five sites during driving at two times diastolic threshold. B,
Effects of propranolol and total autonomic blockade on high intensity
drive train stimulation. The data in A and B are presented as mean
value 6 SD. *p , 0.01. Abbreviations as in Figure 1.
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ERP increase was significantly accentuated when propranolol
was administrated after atropine (Table 1). In group 1A
patients, shortening of the ERP by high intensity S1 stimulation
was significantly reduced after propranolol (Fig. 2B). However,
the effect of high intensity S1 stimulation still existed. After
additional infusion of atropine (autonomic blockade), the
effect of high intensity S1 stimulation was further reduced and
it disappeared at 14 mm away from the S1 stimulation site (Fig.
2B). In group 1B patients, shortening of the ERP by high
intensity S1 stimulation remained similar after atropine infu-
sion, but shortening of the ERP was less after administration of
propranolol (Fig. 3B).
Dispersion of refractoriness at an S1 stimulus intensity of
twice diastolic threshold was 23 6 11 ms. At an S1 stimulus
intensity of 10 mA, the dispersion of refractoriness increased
to 31 6 12 ms (p 5 0.01). After autonomic blockade, the
dispersion of refractoriness was 24 6 12 ms for an S1 stimulus
intensity of twice diastolic threshold and 25 6 11 ms for an S1
intensity of 10 mA (p . 0.05). Thus, the effect of high intensity
S1 stimulation on dispersion of refractoriness was abolished by
autonomic blockade.
Effect of high intensity S1 stimulus at different locations.
The late diastolic capture threshold at the HLRA, RPS and
DCS were 0.52 6 0.15, 0.51 6 0.16 and 0.54 6 0.18 mA,
respectively (p . 0.05). At a stimulus intensity of two times
diastolic threshold, the atrial ERP was 184 6 15 ms at the
HLRA, 200 6 24 ms at the lower RPS and 216 6 19 ms at the
DCS when both S1 and S2 stimuli were delivered at each site.
When the S1 stimulus site moved from the HLRA to the RPS
and DCS, the atrial ERPs of the high lateral wall were 184 6
14 and 183 6 15 ms, respectively (p . 0.05). When the S1
stimulus site moved from the RPS to the HLRA and DCS, the
atrial ERPs of the lower RPS were 199 6 21 and 197 6 22 ms,
respectively (p . 0.05). When the S1 stimulus site moved from
the DCS to the HLRA and the lower RPS, the atrial ERPs of
the DCS were 214 6 17 and 217 6 19 ms, respectively (p .
0.05). Thus, the site of lower intensity S1 stimulation did not
affect the atrial ERP determination.
When the S1 stimulus intensity increased to 10 mA, the
atrial ERP shortened significantly: 220 6 5 ms (210.8 6
2.7%) at the HLRA, 222 6 5 ms (210.8 6 2.2%) at the lower
RPS and 226 6 11 ms (212.2 6 4.6%) at the DCS when both
S1 and S2 stimuli were delivered at the same site. However, the
ERPs did not shorten when the high intensity S1 stimulus
moved to the other two sites.
High intensity S1 stimulation at the HLRA significantly
increased the dispersion of refractoriness from 36 6 17 to 54 6
18 ms (p , 0.001). At the RPS, dispersion of refractoriness was
similar during S1 stimulation at both two times diastolic
threshold and 10 mA (35 6 17 ms vs. 40 6 18 ms, p . 0.05).
In contrast to high intensity S1 stimulation at HLRA, the S1
stimulation at the DCS significantly decreased the dispersion
of refractoriness from 36 6 16 to 23 6 13 ms (p 5 0.008).
Effect of autonomic blockade on high intensity S1 stimulus
at different locations. When given alone, propranolol signifi-
cantly increased the ERP at all three sites (Fig. 4A), whereas
atropine significantly decreased it at all three sites (Fig. 5A).
For group 2A patients, the effect of high intensity S1 stimula-
tion on refractoriness shortening was blunted significantly after
propranolol at all three sites. When atropine was infused after
propranolol, the effect of high intensity S1 stimulation on
refractoriness shortening was still blunted (Fig. 5B). For group
2B patients who received atropine infusion after the baseline
study, the effect of high intensity S1 stimulation on refractori-
ness shortening remained similar at these three atrial sites.
However, after propranolol was added, the effect of high
intensity S1 stimulation was greatly reduced at all three sites
(Fig. 5B).
Figure 3. A, Effects of atropine and total autonomic blockade on ERP
at five sites during driving at two times diastolic threshold. B, Effects of
atropine and total autonomic blockade on high intensity drive-train
stimulation. The data in A and B are presented as mean value 6 SD.
*p , 0.01. Abbreviations as in Figure 1.
Table 1. Prejunctional Vagal Modulation of Sympathetic Effect
S2 Site*





0 mm 16 6 6† 8 6 6
7 mm 16 6 3† 9 6 6
14 mm 21 6 9† 8 6 6
21 mm 21 6 7† 11 6 5
28 mm 22 6 8† 11 6 5
*Distance of extrastimulus (S2) site from site of drive train (S1) stimulation.
†p , 0.02 comparing results with and without atropine pretreatments. Data are
presented as mean value 6 SD. ERP 5 effective refractory period.
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Discussion
Major findings. This study showed that high intensity S1
stimulation caused a decrease in the atrial ERP at the site of
stimulation. This effect was most prominent at the S1 stimula-
tion site and it decayed as the S2 site moved away from the S1
site. In quantitative analysis, shortening of the atrial ERP
disappeared between 21 and 28 mm away from the S1 stimu-
lation site. The high intensity S1 stimulation increased the
dispersion of atrial refractoriness by shortening the atrial ERP
near the site of S1 stimulation. Furthermore, sequential auto-
nomic blockade demonstrated that atropine alone had no
effect on high intensity S1 stimulation; propranolol and total
autonomic blockade markedly blunted the effects.
Studies at different atrial sites showed that the site of low
intensity S1 stimulation did not affect the atrial ERP determi-
nations. Furthermore, the high intensity S1 stimulation had no
effect on the ERP of the different atrial sites remote from the
S1 stimulation. These data further support the view that the
high intensity S1 stimulation caused a local shortening of the
ERP. Finally, high intensity S1 stimulation at the HLRA
increased the dispersion of refractoriness but high intensity S1
stimulation at the DCS decreased the dispersion of refractori-
ness.
Spatial effect of high intensity S1 stimulation on atrial
refractoriness. Greenspan et al. (9) reported that increase of
the intensity of both the S1 stimulus and S2 could shorten the
ventricular effective refractory period (VERP) in human stud-
ies. However, they did not evaluate the effect of the autonomic
nervous system. Langberg et al. (2) showed that increasing S1
stimulation intensity also resulted in shortening of the VERP,
and this effect was attenuated after autonomic blockade.
Goldberger et al. (3) further demonstrated that high intensity
S1 stimulation shortened the VERP maximally at the site of
stimulation, and the VERP shortening dissipated between 7
and 14 mm away from the S1 stimulation site (3). Our study
demonstrated that high intensity S1 stimulation had a similar
effect on atrial refractoriness. However, the shortening of the
ERP in the atrium was more prominent and it dissipated more
slowly. Previous studies (10,11) showed that release of norepi-
nephrine and acetylcholine can be caused by local electrical
stimulation. The autonomic innervation was different between
the atrium and the ventricle (4–6). The atrium was more
densely innervated with both sympathetic and parasympathetic
nerves, so there may be more neuromediators released by high
intensity S1 stimulation in the atrium. Furthermore, the major
Figure 4. A, Effects of propranolol and total autonomic blockade on
ERP at different atrial sites during driving at two times diastolic
threshold. B, Effects of propranolol and total autonomic blockade on
high intensity drive train stimulation at three atrial locations: distal
coronary sinus (DCS); high lateral wall of right atrium (HLRA) and
RPS (right posterior interatrial septum). The data in A and B are
presented as mean value 6 SD. Open bars 5 baseline; hatched bars 5
after propranolol; cross-hatched bars 5 after total autonomic block-
ade. *p , 0.01. Other abbreviations as in Figure 1.
Figure 5. Effect of atropine and total autonomic blockade on ERP at
different atrial sites during driving at two times diastolic threshold. B,
Effects of atropine and total autonomic blockade on high intensity
drive train stimulation at three atrial sites. The data in A and B are
presented as mean value 6 SD. *p , 0.01. Definitions of bars as in
Figure 4; abbreviations as in Figures 1 and 4.
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neuromediators released by electrical stimulation have differ-
ent effects on the atrium and ventricle. Norepinephrine short-
ens the ERPs of both the atrium and the ventricle; acetylcho-
line prolongs the VERP but shortens the atrial ERP (12–15).
High-intensity S1 stimulation releases both norepinephrine
and acetylcholine; they have a synergistic effect on the short-
ening of the atrial ERP but an antagonistic effect on the
VERP. Thus, the high intensity S1 stimulus had a more intense
effect on atrial than on ventricular refractoriness.
Data from sequential autonomic blockade further sup-
ported this phenomenon. After atropine infusion, the atrial
ERP shortened and the effects of high intensity S1 stimulation
did not change; reflex sympathetic activation or loss of inhibi-
tion of the parasympathetic limb might be the cause (16–19).
Our data showed that propranolol infusion increased the ERP
more prominently after pretreatment with atropine. Further-
more, atropine could not shorten the atrial ERP during
sympathetic nerve blockade. Thus, atropine shortening of the
ERP might be due to prejunctional modulation of sympathetic
effect. In contrast, propranolol infusion increased the atrial
ERP and blunted the effect of high intensity S1 stimulation.
Moreover, infusion of atropine and propranolol was more
effective than infusion of propranolol alone in abolishing the
effect of high intensity S1 stimulation. Thus, the atropine and
propranolol had a synergistic effect in blocking the shortening
of refractoriness caused by high intensity S1 stimulation.
High-intensity S1 stimulation resulted in an increase in the
dispersion of atrial refractoriness. There were no significant
differences in the mean refractory period among all sites at
twice diastolic threshold. The high intensity stimulation short-
ened the atrial ERP more prominently at the S1 stimulation
site. Thus, high intensity S1 stimulation increased the disper-
sion of refractoriness. After autonomic blockade, the atrial
ERP shortening caused by high intensity S1 stimulation be-
came blunted and the dispersion of refractoriness disappeared.
Effects of high intensity S1 stimulation at different loca-
tions. This study demonstrated that changing the site of low
intensity S1 stimulation did not affect ERP determination.
These data were similar to those studied at the ventricle (3).
Furthermore, high intensity S1 stimulation could shorten the
ERP of local atrial tissue, as occurred in our group 1. This
effect disappeared as S2 moved far away from the S1 stimula-
tion site, and it became blunted after autonomic blockade.
These findings further support the view that autonomic neu-
rotransmitters played an important role in this phenomenon.
This study also demonstrated that at low intensity S1 stimula-
tion, the ERPs were inhomogeneous; the HLRA had the
shortest ERP, the DCS the longest. The high intensity S1
stimulation further decreased the ERP at the S1 stimulation
site. Thus, high intensity S1 stimulation applied to the HLRA
resulted in increased dispersion of atrial refractoriness. When
it was applied to the DCS, local shortening of the ERP
occurred and the ERP became more homogeneous. Thus, the
dispersion of refractoriness was decreased.
Anisotropic conduction and inhomogeneity of refractori-
ness in atrial tissue were considered to be the arrhythmogenic
mechanisms of atrial arrhythmia (20–22). Allessie et al. (22)
demonstrated that nonuniform recovery of excitability formed
the substrate for initiation and maintenance of reentrant
tachycardia in atrial tissue. Atrial tachyarrhythmia was more
easily induced with high intensity atrial stimuli because they
increased dispersion of refractoriness, which favored initiation
and maintenance of reentrant arrhythmia. Whether or not the
high intensity drive stimulation could change the anisotropic
conduction needs further study.
Limitations of the study. The effect of high intensity S1
stimulation could not be completely abolished with atropine
and propranolol. Because propranolol and atropine are com-
petitive inhibitors of the beta-receptor and muscarinic recep-
tors, high intensity S1 stimulation might result in high local
levels of catecholamines and acetylcholine, which could over-
come the competitive effect of propranolol and atropine.
Whether high doses of beta-blockade or atropine would com-
pletely block the effects of high intensity S1 stimulation were
not tested. Furthermore, the atrial neurotransmitters were
complex and the effects of other atrial neurotransmitters on
different receptors and their effects on high intensity S1
stimulation were not evaluated.
Conclusions. High intensity S1 stimulation caused local
shortening of the ERP near the stimulation site and increased
the dispersion of refractoriness in atrial tissue. These effects
were markedly blunted after infusion of propranolol and total
autonomic blockade.
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